Patent · US Active

Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof

US9561264B2 · kind B2 · utility

8Cited by

13References

5Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Markus Frank · Baden-Baden, DE
Mohamed H. Sayegh · Dedham, US

Key dates

Filing date	Jul 10, 2013
Grant date	Feb 7, 2017
Priority date	—
Expiry date	Jul 10, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an MDR family P-glycoprotein located on human chromosome 7p15-21, polynucleotide sequences encoding this P-glycoprotein and fragments thereof. This gene is utilized in methods for assessing cancer cell susceptibility to therapies directed against multidrug resistance, and for the design of diagnostic and therapeutic methods relating to cancer multidrug resistance. The invention also relates to methods for determining whether a test compound may inhibit multidrug resistance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.